Pressrelease 10 January 2006
Changes in Board of Directors
Glucox Biotech announces changes in its Board of Directors by election of Erik Walum, professor in Neurochemistry from Stockholm University with numerous years of experience within the pharmacology field. He has served as head of Pharmacology at Pharmacia&Upjohn. Presently he holds a position as scientific manager at Biovitrum in Stockholm, Sweden.
Download a pdf of the Pressrelease
Pressrelease 15 May 2007
Promising Results in Treatment with GLX
Pressrelease 29 December 2006
US Patent Received for Diabetes Treatment
Pressrelease 28 September 2006
Glucox' Unique Research Discovery Confirmed by US Scientist
Pressrelease 10 July 2006
Patent Application Submitted for the GLX Compounds
Pressrelease 5 June 2006
A Significant Preclinical Milestone Achieved
Pressrelease 7 February 2006
Positive Results from the First Time In Animal Study
Pressrelease 10 January 2006
Pressrelease 10 November 2005
Evaluation and Selection of Glucox Biotech' Lead Drug Candidates